What is the primary pathophysiological process that occurs in disseminated intravascular coagulation (DIC)?
Decreased production of clotting factors
Impaired platelet function
Excessive activation of clotting factors and widespread clot formation
Excessive platelet production
The Correct Answer is C
A. DIC is not characterized by decreased production of clotting factors. Instead, it involves consumption of clotting factors due to widespread activation of coagulation.
B. While platelet dysfunction may occur in DIC due to consumption and depletion of platelets, the primary pathophysiological process in DIC is the activation of clotting factors and formation of blood clots throughout the vasculature.
C. Excessive activation of clotting factors and widespread clot formation is the primary pathophysiological process in DIC. This leads to the formation of numerous small blood clots throughout the body's blood vessels, resulting in organ dysfunction and potentially life-threatening complications.
D. Excessive platelet production is not a characteristic feature of DIC. Instead, platelets are consumed and depleted as they are incorporated into the blood clots formed during the
coagulation cascade in DIC.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
A. Phalitis: This term is not commonly used and does not specifically refer to swelling in the hands and feet.
B. Dactylitis: Dactylitis is a common manifestation of sickle cell disease in infants, characterized by painful swelling of the hands and feet due to vaso-occlusive episodes.
C. Erythromelaglia: Erythromelalgia is a condition characterized by burning pain, redness, and warmth in the extremities, but it is not typically associated with sickle cell disease.
D. Dyshidrotia: This term is not commonly used in medical terminology and does not specifically refer to swelling in the hands and feet.
Correct Answer is B
Explanation
A. Cyclosporine. While cyclosporine is used to treat aplastic anemia, particularly in cases of immune-mediated aplastic anemia, it is not considered a potential cure.
B. Stem cell transplantation. Stem cell transplantation is both a standard treatment and a potential cure for aplastic anemia, especially for younger patients with a suitable donor.
C. Plasmapheresis. Plasmapheresis is not a standard treatment for aplastic anemia.
D. Transfusions. Blood transfusions are a supportive treatment for aplastic anemia but not a cure.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.